{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=physiologic+testing&page=6", "query": { "intervention": "physiologic testing", "page": 6 }, "page_size": 10 }, "pagination": { "page": 6, "page_size": 10, "total_count": 1025, "total_pages": 103, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=physiologic+testing&page=7&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=physiologic+testing&page=5&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-18T03:02:56.977Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02160587", "title": "Safety Study to Evaluate the Contact Sensitizing Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Surgical Site Infection" ], "interventions": [ { "name": "Chloraprep", "type": "DRUG" }, { "name": "0.9% Physiological Saline", "type": "DRUG" }, { "name": "ZuraPrep without IPA", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Zurex Pharma, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 208, "start_date": "2014-07", "completion_date": "2014-10", "has_results": false, "last_update_posted_date": "2015-03-17", "last_synced_at": "2026-10-18T03:02:56.977Z", "location_count": 1, "location_summary": "Bozeman, Montana", "locations": [ { "city": "Bozeman", "state": "Montana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02160587" }, { "nct_id": "NCT02157207", "title": "Racial and Aging Effects of Acute Antioxidant Supplementation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Antioxidant", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "University of Illinois at Chicago", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 93, "start_date": "2014-04", "completion_date": "2015-06", "has_results": false, "last_update_posted_date": "2015-06-16", "last_synced_at": "2026-10-18T03:02:56.977Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02157207" }, { "nct_id": "NCT04540536", "title": "Feasibility and Effectiveness of Real-time, Remote Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus, Type 1", "Noncompliance, Patient" ], "interventions": [ { "name": "Continuous Glucose Monitoring", "type": "OTHER" }, { "name": "Secure texting", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "13 Years to 18 Years" }, "enrollment_count": 20, "start_date": "2021-11-01", "completion_date": "2024-12-01", "has_results": true, "last_update_posted_date": "2026-03-03", "last_synced_at": "2026-10-18T03:02:56.977Z", "location_count": 2, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04540536" }, { "nct_id": "NCT03448393", "title": "CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Lymphoma, Non-Hodgkin", "Leukemia, Lymphocytic, B Cell", "B-Cell Lymphoma", "B-Cell Leukemia", "Acute Lymphoid Leukemia", "B-Non Hodgkin Lymphoma", "B-NHL", "B-All", "Acute Lymphoblastic Leukemia", "Acute Lymphocytic Leukemia" ], "interventions": [ { "name": "CD19/CD22 CAR T-Cells", "type": "BIOLOGICAL" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Apheresis", "type": "PROCEDURE" }, { "name": "Anti-emetic", "type": "OTHER" }, { "name": "Diphenhydramine", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "ECG", "type": "DIAGNOSTIC_TEST" }, { "name": "ECHO", "type": "DIAGNOSTIC_TEST" }, { "name": "MRI Brain", "type": "DIAGNOSTIC_TEST" }, { "name": "Bone marrow biopsy", "type": "PROCEDURE" }, { "name": "Cardiac MRI", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "PROCEDURE", "OTHER", "DIAGNOSTIC_TEST" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "39 Years", "sex": "ALL", "summary": "3 Years to 39 Years" }, "enrollment_count": 54, "start_date": "2018-03-26", "completion_date": "2025-01-13", "has_results": true, "last_update_posted_date": "2025-06-04", "last_synced_at": "2026-10-18T03:02:56.977Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03448393" }, { "nct_id": "NCT02741336", "title": "Electrophysiologic Changes in Blacks Treated With CBT for Insomnia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Insomnia" ], "interventions": [ { "name": "Cognitive Behavioral Therapy for Insomnia (CBT-I)", "type": "BEHAVIORAL" }, { "name": "Self-Monitoring", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "State University of New York - Downstate Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "30 Years to 50 Years · Female only" }, "enrollment_count": 10, "start_date": "2015-11", "completion_date": "2017-06", "has_results": false, "last_update_posted_date": "2017-09-13", "last_synced_at": "2026-10-18T03:02:56.977Z", "location_count": 1, "location_summary": "Brooklyn, New York", "locations": [ { "city": "Brooklyn", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02741336" }, { "nct_id": "NCT04750941", "title": "Study of Copanlisib and Ketogenic Diet", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Follicular Lymphoma", "Endometrial Cancer" ], "interventions": [ { "name": "Copanlisib", "type": "DRUG" }, { "name": "Ketogenic Diet", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1, "start_date": "2022-02-10", "completion_date": "2023-06-09", "has_results": true, "last_update_posted_date": "2025-03-04", "last_synced_at": "2026-10-18T03:02:56.977Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04750941" }, { "nct_id": "NCT03999229", "title": "S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Transfusion Related Complication" ], "interventions": [ { "name": "SNO", "type": "DRUG" }, { "name": "Normal Saline", "type": "DRUG" }, { "name": "Red Blood Cell", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "James Reynolds", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "18 Years to 35 Years" }, "enrollment_count": 35, "start_date": "2019-07-25", "completion_date": "2028-02-29", "has_results": false, "last_update_posted_date": "2025-12-02", "last_synced_at": "2026-10-18T03:02:56.977Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03999229" }, { "nct_id": "NCT04632849", "title": "The Use of Libre to Improve Metabolic Control and Reduce Reliance on Medication", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "GEM + CGM", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Virginia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "35 Years to 85 Years" }, "enrollment_count": 17, "start_date": "2020-11-01", "completion_date": "2021-09-01", "has_results": false, "last_update_posted_date": "2021-10-05", "last_synced_at": "2026-10-18T03:02:56.977Z", "location_count": 1, "location_summary": "Charlottesville, Virginia", "locations": [ { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04632849" }, { "nct_id": "NCT04847050", "title": "A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Solid Tumor Malignancy", "Hematologic Malignancy", "Leukemia", "Lymphoma", "Multiple Myeloma" ], "interventions": [ { "name": "Messenger ribonucleic acid (mRNA)-1273 Vaccine", "type": "BIOLOGICAL" }, { "name": "Messenger ribonucleic acid (mRNA)-1273 Vaccine Booster", "type": "BIOLOGICAL" }, { "name": "ECG", "type": "DIAGNOSTIC_TEST" }, { "name": "Antibiotics", "type": "OTHER" }, { "name": "Anti-viral agents", "type": "OTHER" }, { "name": "Anti-fungal agent", "type": "OTHER" }, { "name": "Anti-emetics", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "DIAGNOSTIC_TEST", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 19, "start_date": "2021-04-28", "completion_date": "2023-05-25", "has_results": true, "last_update_posted_date": "2024-08-27", "last_synced_at": "2026-10-18T03:02:56.977Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04847050" }, { "nct_id": "NCT03328858", "title": "Ketogenic Diet in Children With Malignant or Recurrent/Refractory Brain Tumor", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Brain Tumors" ], "interventions": [ { "name": "Ketogenic Diet", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Nicklaus Children's Hospital f/k/a Miami Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Months", "maximum_age": "35 Years", "sex": "ALL", "summary": "12 Months to 35 Years" }, "enrollment_count": 2, "start_date": "2017-11-01", "completion_date": "2020-01-31", "has_results": false, "last_update_posted_date": "2020-02-05", "last_synced_at": "2026-10-18T03:02:56.977Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03328858" } ] }